ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,193.49
-2.86%
US Tech 100
17,395.60
-3.09%
Dow Jones
38,774.93
-2.42%
Brent Oil
76.04
-1.41%
Bitcoin
54,167.95
-6.35%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
08/01/20243:44PMBusiness WireUS FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefitNYSE:GSKGSK plc
07/31/202412:28PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/30/20246:03AMIH Market NewsF5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback ProgramNYSE:GSKGSK plc
07/29/20246:24AMIH Market NewsApple Delays AI Features, Abbott Shares Plunge 7% After $495M Fine, Philips Soars 10%NYSE:GSKGSK plc
07/29/20246:23AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/29/20246:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/19/20247:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/18/202411:53AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/16/202410:44AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/15/20241:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/12/202411:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
07/11/20248:00AMBusiness WireGSK Begins Shipping Influenza Vaccine Doses for 2024-25 SeasonNYSE:GSKGSK plc
07/03/20246:59AMIH Market NewsApple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More NewsNYSE:GSKGSK plc
06/27/20247:13AMIH Market NewsInteractive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More NewsNYSE:GSKGSK plc
06/07/20246:57PMBusiness WireUS FDA Approves Expanded Age Indication for GSK’s AREXVY, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased RiskNYSE:GSKGSK plc
06/03/20248:10AMBusiness WireJemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancerNYSE:GSKGSK plc
06/02/202410:56AMBusiness WireBelantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myelomaNYSE:GSKGSK plc
05/24/20246:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/21/20247:18AMIH Market NewsCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils Copilot+ PCs with AI Focus, and More NewsNYSE:GSKGSK plc
05/21/20246:17AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/20/202410:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/17/20247:36AMIH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:GSKGSK plc
05/17/20246:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/13/202410:49AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
05/07/20241:00AMGlobeNewswire Inc.BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 MillionNYSE:GSKGSK plc
04/26/20247:48AMIH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:GSKGSK plc
03/16/20248:00AMBusiness WirePositive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancerNYSE:GSKGSK plc
03/08/202412:48PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
03/07/202412:00PMBusiness WireGSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising RiseNYSE:GSKGSK plc
03/07/20246:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

BIT
MB
Mediobanca Banca di Cred...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved